Glycosylation of β-Lipoprotein and the Possible Role of Choline Derivatives

1974 ◽  
Vol 52 (5) ◽  
pp. 359-365 ◽  
Author(s):  
Thomas Delahunty ◽  
Sailen Mookerjea

(1) The incorporation of [1-14C]glucosamine and UDP-N-acetyl-[1-14C]glucosamine into β-lipoprotein was studied with rat liver slices and subcellular particles, respectively. β-Lipoprotein released into the medium was isolated by a modified heparin precipitation technique. The lecithin–protein ratios of heparin precipitable β-lipoprotein from the medium of liver microsomes and of serum were found to be very similar. With microsomes a substantial incorporation was obtained which reached a maximum in 12 min and 27 °C. The enzymatic attachment of the amino sugar to the apoprotein was further indicated when the incorporation was correlated with the quantity of microsomal protein present.(2) As shown previously with other protein acceptors, the addition of choline derivatives caused a considerable stimulation in incorporation of the label for slices, microsomes, and purified rough microsomes. The effect of CDP-choline on glycosylation was not as great when a Golgi-rich membrane fraction was used, suggesting that the major stimulation occurred at the sites of lipoprotein synthesis rather than secretion.(3) The release of prelabelled β-lipoprotein from liver slices was not enhanced by the addition of phosphorylcholine or excess glucosamine to the medium, suggesting that increased carbohydrate coupling does not stimulate secretion.

1998 ◽  
Vol 72 (4) ◽  
pp. 207-214 ◽  
Author(s):  
Alessandra Turini ◽  
Giada Amato ◽  
Vincenzo Longo ◽  
Pier Giovanni Gervasi

1985 ◽  
Vol 230 (1) ◽  
pp. 19-24 ◽  
Author(s):  
H Seltman ◽  
W Diven ◽  
M Rizk ◽  
B J Noland ◽  
R Chanderbhan ◽  
...  

Sterol carrier protein2 (SCP2) is known to stimulate utilization of cholesterol in enzymic reactions in which cholesterol is the substrate. Substantial recent experimental evidence indicates that SCP2: activates enzymic conversion of intermediates between lanosterol and cholesterol; stimulates the microsomal conversion of cholesterol into cholesterol ester in rat liver; and enhances mitochondrial utilization of cholesterol for pregnenolone formation in the adrenals. The conversion of cholesterol into 7 α-hydroxycholesterol is the rate-limiting step in bile-acid synthesis. We therefore investigated the effect of SCP2 on this physiologically critical reaction by using a gas-chromatography-mass-spectrometry procedure that measures the mass of 7 α-hydroxycholesterol formed. The results show that SCP2 enhances 7 α-hydroxycholesterol formation by rat liver microsomes (microsomal fractions), utilizing either endogenous membrane cholesterol, cholesterol supplied exogenously in serum or in the form of cholesterol/phospholipid liposomes. Microsomes immunotitrated with anti-SCP2 antibody exhibited considerably less capacity to synthesize 7 α-hydroxycholesterol, which was restored to control levels on addition of purified SCP2. These data are consistent with the suggestion that SCP2 may be of physiological significance in the overall metabolism of cholesterol.


FEBS Letters ◽  
1983 ◽  
Vol 163 (1) ◽  
pp. 136-139 ◽  
Author(s):  
Giorgio Bellomo ◽  
Francesca Mirabelli ◽  
Plinio Richelmi ◽  
Sten Orrenius

Sign in / Sign up

Export Citation Format

Share Document